Johnson & Johnson Announces Collaboration with Sail Biomedicines to Advance in vivo CAR-T Programs and Transform Autoimmune Disease Through Immune Reset
Go back to Johnson & Johnson Announces Collaboration with Sail Biomedicines to Advance in vivo CAR-T Programs and Transform Autoimmune Disease Through Immune Reset| Johnson & Johnson (NYSE: JNJ) | Delayed: 270.22 +2.94 (1.10%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $267.28 | 52 Week High | $126.07 | |||
| Open | $268.00 | 52 Week Low | $94.28 | |||
| Day High | $270.87 | P/E | 56.18 | |||
| Day Low | $267.11 | EPS | $4.81 | |||
| Volume | 6,369,281 | |||||
